98-24626. Rohm and Haas Co.; Filing of Food Additive Petition  

  • [Federal Register Volume 63, Number 178 (Tuesday, September 15, 1998)]
    [Notices]
    [Page 49360]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-24626]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98F-0749]
    
    
    Rohm and Haas Co.; Filing of Food Additive Petition
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that Rohm 
    and Haas Co. has filed a petition proposing that the food additive 
    regulations be amended to provide for the safe use of the ion exchange 
    resin, methylacrylate-divinyl benzene diethylene glycol divinyl ether 
    terpolymer to treat water and aqueous foods without limits on the 
    conditions of use, and with a specification for 
    dimethylaminopropylamine, an impurity in the ion exchange resin.
    
    FOR FURTHER INFORMATION CONTACT: James C. Wallwork, Center for Food 
    Safety and Applied Nutrition (HFS-215),Food and Drug Administration, 
    200 C St. SW., Washington, DC 20204, 202-418-3078.
    
    SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
    Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food 
    additive petition (FAP 8A4609) has been filed by Rohm and Haas Co., 100 
    Independence Mall West, Philadelphia, PA 19106-2399. The petition 
    proposes to amend the food additive regulations in Sec. 173.25 Ion 
    exchange resins (21 CFR 173.25) to provide for the safe use of the ion 
    exchange resin, methylacrylate-divinyl benzene diethylene glycol 
    divinyl ether terpolymer, identified in Sec. 173.25(a)(16), to treat 
    water and aqueous foods as described in Sec. 173.25(b)(2), without 
    limits on the conditions of use, and with a specification for 
    dimethylaminopropylamine, an impurity in the ion exchange resin.
        The agency has determined under 21 CFR 25.32(j) that this action is 
    of a type that does not individually or cumulatively have a significant 
    effect on the human environment. Therefore, neither an environmental 
    assessment nor an environmental impact statement is required.
    
        Dated: August 31, 1998.
    Laura M. Tarantino,
    Acting Director, Office of Premarket Approval, Center for Food Safety 
    and Applied Nutrition.
    [FR Doc. 98-24626 Filed 9-14-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
09/15/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-24626
Pages:
49360-49360 (1 pages)
Docket Numbers:
Docket No. 98F-0749
PDF File:
98-24626.pdf